Pediatric Psoriasis Market Growth – at a CAGR of 10.3% During Forecast Period 2020-2028

Growing awareness of rare diseases and high incidence rate of psoriasis among children and infants are among the key factors driving the global market revenue growth

Emergen Research has published its latest report titled “Pediatric Psoriasis Market, By Type (Plaque psoriasis, Guttate psoriasis, Pustular psoriasis, Inverse psoriasis, Erythrodermic psoriasis, Mucosal/oral psoriasis, Nail psoriasis, Napkin or diaper psoriasis, Photosensitive psoriasis, Flexural psoriasis), By Treatment (Topical therapy, Oral, Injections, Biologics, Natural supplements, Phototherapy), By End-use (Hospitals, Specialty clinics, Ambulatory care centers, Research organizations), and By Region Forecast to 2028”

According to Emergen Research, the global pediatric psoriasis market size was USD 10.76 billion in 2020 and is expected to reach USD 23.58 billion in 2028 and register a revenue CAGR of 10.3% during the forecast period, 2021-2028.

Click Here to Access Free sample PDF Copy of the Report@

Market Dynamics:

The global pediatric psoriasis market revenue growth is primarily driven by factors such as growing incidence rate of psoriasis among children and infants across the globe, increasing awareness of early detection and treatment of chronic skin diseases, rise in research & development activities for development of advanced biologics with higher clinical efficacy, and growing demand for more advanced and cost-effective drugs for treatment of pediatric psoriasis. Psoriasis is a non-infectious skin condition that causes skin cells to grow more rapidly than usual, building up thick, itchy, and silvery scales on the skin’s surface called plaques. The condition is mostly associated with an overactive immune system and can also be passed from one generation to another.

Psoriasis in children, known as pediatric psoriasis, generally shows mild or moderate symptoms and can be treated with medication. The condition can be categorized into three different types, including pediatric psoriasis with psoriatic arthritis, psoriasis with early-onset, and self-limited disease of infancy. The most common symptoms of pediatric psoriasis include red, dry, and itchy patches of skin, frequent soreness, bleeding, or a burning sensation in the affected areas, and various changes in nails, such as thick and pitted fingernails and yellowing of the nails. Increasing regulatory approvals for new and more effective psoriasis drugs and therapeutics are expected to further drive the global pediatric psoriasis market revenue growth. For instance, U.S. FDA granted approval for the promising drug Ustekinumab for plaque psoriasis in children in July 2020.

COVID-19 Impact Analysis:

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants  continue to cause concerns and impact normal routines

Topical Therapy Segment Accounted for Largest Revenue Share in 2020:

Based on treatment, the global pediatric psoriasis market is segmented into topical therapy, oral, injections, biologics, natural supplements, and phototherapy. The topical therapy segment dominated other segments in terms of revenue share in the global market in 2020. Rising awareness chronic skin diseases, increasing cases of pediatric psoriasis worldwide, rise in research & development activities for advanced drugs and therapies, and growing demand for topical therapies for pediatric psoriasis treatment are key factors driving revenue growth of this segment.

Looking for Discount [Click on the link] @

Hospitals Segment to Account for Fastest Revenue CAGR:

Based on end-use, the global pediatric psoriasis market is segmented into hospitals, specialty clinics, ambulatory care centers, and research organizations. The hospitals segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Increasing cases of severe pediatric psoriasis, growing rate of hospital admissions, and rapid adoption of safer and more advanced drugs and therapeutics for treatment of pediatric psoriasis are among the major factors supporting revenue growth of this segment.

North America Accounted for Largest Revenue Share in 2020:

Among regional markets, the North America pediatric psoriasis market accounted for the largest revenue share in the global market in 2020. Increasing incidence of psoriasis among children and infants, rising awareness of chronic skin diseases, increasing research & development activities to develop advanced biologics, growing demand for more advanced and drugs & therapeutics for pediatric psoriasis treatment, and presence of leading market players in the region, including Amgen Inc., Johnson & Johnson, and Eli Lilly & Company, are key factors driving the North America market revenue growth.

Major Companies in the Global Pediatric Psoriasis Market Include:

  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson
  • Novartis AG
  • Eli Lilly & Company
  • AstraZeneca
  • Celgene Corporation
  • Merck
  • Boehringer Ingelheim
  • LEO Pharma
  • UCB

Have a look at Report Description and Table of Contents of Market Report@

For the purpose of this report, Emergen Research has segmented the global pediatric psoriasis market on the basis of type, treatment, end-use, and region:

Type Outlook (Revenue, USD Billion; 2018-2028)

  • Plaque psoriasis
  • Guttate psoriasis
  • Pustular psoriasis
  • Inverse psoriasis
  • Erythrodermic psoriasis
  • Mucosal/oral psoriasis
  • Nail psoriasis
  • Napkin or diaper psoriasis
  • Photosensitive psoriasis
  • Flexural psoriasis

Treatment Outlook (Revenue, USD Billion; 2018-2028)

  • Topical therapy
  • Oral
  • Injections
  • Biologics
  • Natural supplements
  • Phototherapy

End-use Outlook (Revenue, USD Billion; 2018-2028)

  • Hospitals
  • Specialty clinics
  • Ambulatory care centers
  • Research organizations

Region Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of Middle East & Africa

Explore more reports offered by Emergen Research:

The global patient engagement solutions market is estimated to grow at a CAGR of 15.1% from USD 11.77 billion in 2019 to USD 41.20 billion in 2027. The patient engagement solutions market is driven mainly by the growing use of electronic health records for patient-centered care and the adoption of mobile health apps.

The global regenerative medicine market is estimated to grow at a CAGR of 9.3% from USD 3.05 billion in 2019 to USD 6.49 billion in 2027. A strong product pipeline and government and private investment to support research are expected to fuel growth in clinical trials.

The global next generation sequencing market is forecasted to grow at a rate of 10.9% from USD 9.67 Billion in 2019 to USD 23.59 Billion in 2027. The reduction of sequencing costs is projected to lead to a large number of clinical areas in the Next Generation Sequencing (NGS).

The global RFID in healthcare market is forecasted to grow at a rate of 15.0% from USD 3.69 Billion in 2019 to USD 12.89 Billion in 2027. Certain factors, such as a growing operational cost savings necessity, the implementation of RFID in health care, and patient safety requirements, are driving the market.

The global Newborn Screening Market is forecasted to grow at a rate of 10.3% in terms of value, from USD 1.03 billion in 2019 to reach USD 2.27 billion by 2027. Growing neonatal population base, increasing Newborn congenital disease events, favorable government initiatives & regulations, and developments in technology are expected to serve as critical drivers of the Newborn screening market.

 About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Read Our Press release@

Back to news